Skip to main content

Table 1 Baseline patient and tumor characteristics

From: FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma

Characteristic Total (n = 15)
Age, (years)
 Mean (SD) 71.5 (8.8)
 Median [range] 73.0 [55.0–84.0]
 IQR 65.0–78.0
Sex, n (%)
 Female 1 (7%)
 Male 14 (93%)
ECOG at treatment, n (%)
 0 7 (47%)
 1 8 (53%)
Duration of cemiplimab treatment (months)
 Median (range) 22 (8–24)